Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease
Open Access
- 30 September 2005
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 11 (9), 680-687
- https://doi.org/10.1016/j.bbmt.2005.05.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systemsTransplantation and Cellular Therapy, 2002
- A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host diseaseTransplantation and Cellular Therapy, 2000
- Pathophysiologic mechanisms of acute graft-vs.-host diseaseTransplantation and Cellular Therapy, 1999
- A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatmentBlood, 1991
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990
- Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trialBritish Journal of Haematology, 1989
- Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialBlood, 1989
- Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsBlood, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986